Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.

van den Heuvel-Eibrink MM, van der Holt B, Burnett AK, Knauf WU, Fey MF, Verhoef GE, Vellenga E, Ossenkoppele GJ, Löwenberg B, Sonneveld P.

Ann Hematol. 2007 May;86(5):329-37. Epub 2007 Mar 6.

2.

Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).

van den Heuvel-Eibrink MM, Wiemer EA, Prins A, Meijerink JP, Vossebeld PJ, van der Holt B, Pieters R, Sonneveld P.

Leukemia. 2002 May;16(5):833-9.

3.

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.

Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McConnell TS, Head DR, Weick J, Grever MR, Appelbaum FR, Willman CL.

Blood. 1999 Aug 1;94(3):1086-99.

4.

FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.

Nasilowska-Adamska B, Solarska I, Paluszewska M, Malinowska I, Jedrzejczak WW, Warzocha K.

Ann Hematol. 2014 Apr;93(4):577-93. doi: 10.1007/s00277-013-1898-7. Epub 2013 Sep 13.

PMID:
24030729
5.

Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia.

de Figueiredo-Pontes LL, Pintão MC, Oliveira LC, Dalmazzo LF, Jácomo RH, Garcia AB, Falcão RP, Rego EM.

Cytometry B Clin Cytom. 2008 May;74(3):163-8. doi: 10.1002/cyto.b.20403.

6.
7.

Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies.

Sun Z, Zhao Z, Li G, Dong S, Huang Z, Ye L, Liang H, Qu J, Ai X, Zhang W, Chen X.

Tumori. 2010 Jan-Feb;96(1):90-6.

PMID:
20437864
9.

Expression of the human major vault protein LRP in acute myeloid leukemia.

Hart SM, Ganeshaguru K, Scheper RJ, Prentice HG, Hoffbrand AV, Mehta AB.

Exp Hematol. 1997 Nov;25(12):1227-32.

PMID:
9357965
10.

Novel mechanisms of drug resistance in leukemia.

Ross DD.

Leukemia. 2000 Mar;14(3):467-73. Review.

PMID:
10720143
11.

Expression of efflux transporters in human ocular tissues.

Chen P, Chen H, Zang X, Chen M, Jiang H, Han S, Wu X.

Drug Metab Dispos. 2013 Nov;41(11):1934-48. doi: 10.1124/dmd.113.052704. Epub 2013 Aug 26.

12.

Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy.

Li J, Li ZN, Yu LC, Bao QL, Wu JR, Shi SB, Li XQ.

Lung Cancer. 2010 Jul;69(1):116-22. doi: 10.1016/j.lungcan.2009.09.013. Epub 2009 Oct 28.

PMID:
19875192
13.

The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.

Li G, Chen X, Wang Q, Xu Z, Zhang W, Ye L.

J Huazhong Univ Sci Technolog Med Sci. 2007 Apr;27(2):173-5.

PMID:
17497289
14.

Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.

Stam RW, van den Heuvel-Eibrink MM, den Boer ML, Ebus ME, Janka-Schaub GE, Allen JD, Pieters R.

Leukemia. 2004 Jan;18(1):78-83.

PMID:
14574327
15.
16.

ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.

Svirnovski AI, Shman TV, Serhiyenka TF, Savitski VP, Smolnikova VV, Fedasenka UU.

Hematology. 2009 Aug;14(4):204-12. doi: 10.1179/102453309X426218.

PMID:
19635183
17.

Expression of multidrug resistance-related transporters in human breast carcinoma.

Kanzaki A, Toi M, Nakayama K, Bando H, Mutoh M, Uchida T, Fukumoto M, Takebayashi Y.

Jpn J Cancer Res. 2001 Apr;92(4):452-8.

18.

Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.

den Boer ML, Pieters R, Kazemier KM, Rottier MM, Zwaan CM, Kaspers GJ, Janka-Schaub G, Henze G, Creutzig U, Scheper RJ, Veerman AJ.

Blood. 1998 Mar 15;91(6):2092-8.

19.

Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.

Diestra JE, Condom E, Del Muro XG, Scheffer GL, Pérez J, Zurita AJ, Muñoz-Seguí J, Vigués F, Scheper RJ, Capellá G, Germà-Lluch JR, Izquierdo MA.

J Urol. 2003 Oct;170(4 Pt 1):1383-7.

PMID:
14501774
20.

Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia.

List AF, Spier CS, Grogan TM, Johnson C, Roe DJ, Greer JP, Wolff SN, Broxterman HJ, Scheffer GL, Scheper RJ, Dalton WS.

Blood. 1996 Mar 15;87(6):2464-9.

Supplemental Content

Support Center